Passage Bio (PASG) stock price prediction is 0 USD. The Passage Bio stock forecast is 0 USD for September 09, Tuesday with technical analysis. Can Indians buy Passage Bio Inc shares? Yes, Indians can invest in the Passage Bio Inc (PASG) from India. With INDmoney, you can buy Passage Bio Inc at 0. Passage Bio has a consensus price target of $ Q. What is the current price for Passage Bio (PASG)?. A. The stock. Stock Price Forecast. The 2 analysts with month price forecasts for Passage Bio stock have an average target of , with a low estimate of and a high. Passage Bio Forecast Revenue Growth Analysts estimate an earnings increase this quarter of $ per share, a decrease next quarter of $ per share, an.
How much is Passage Bio's stock price per share? (NASDAQ: PASG) Passage Bio stock price per share is $ today (as of Aug 28, ). · What is Passage Bio's. Passage Bio, Inc. (PASG) stock forecast and price target · PASGPassage Bio, Inc. (%). At close: PM · Recommendation Rating. 1. Find the latest Passage Bio, Inc. (PASG) stock quote, history, news and other vital information to help you with your stock trading and investing. Trade Passage Bio, Inc. - PASG CFD ; Prev. Close, ; Open, ; 1-Year Change, % ; Day's Range, - The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its. The current price of PASG is USD — it has increased by % in the past 24 hours. Watch Passage Bio, Inc. stock price performance more closely on the. View Passage Bio, Inc. PASG stock quote prices, financial information, real-time forecasts, and company news from CNN. Passage Bio Market Cap: M, Enterprise value: M, P/E: , PEG ratio: , EPS: , Revenue: N/A, EBITDA: M, Income: M. Stock price target for Passage Bio Inc PASG are on downside and on upside. Stock price target for Passage Bio Inc PASG are on downside and On average, analysts forecast that PASG's EPS will be -$ for , with the lowest EPS forecast at -$, and the highest EPS forecast at -$ On. Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases.
Based on short-term price targets offered by four analysts, the average price target for Passage Bio, Inc. comes to $ The forecasts range from a low of. Stock Quote: NASDAQ GS: PASG ; Day's Open. $ ; Volume. 74, ; Intraday High. $ ; Intraday Low. $ ; Closing Price. $ What was Passage Bio's price range in the past 12 months? Passage Bio lowest stock price was $ and its highest was $ in the past 12 months. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Discover Passage Bio's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. According to analysts, PASG price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. The Wall Street analyst predicted that Passage Bio's share price could reach $ by May 15, The average Passage Bio stock price prediction forecasts a. Based on analysts offering 12 month price targets for PASG in the last 3 months. The average price target is $10 with a high estimate of $13 and a low.
Stock Charts · Real-Time Data: Get up-to-the-minute updates on Passage Bio Inc's stock price, ensuring you have the latest information at your fingertips. According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Passage Bio is $, with a. Get Passage Bio Inc (PASG:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since it has more than doubled. Passage Bio Inc Stock (PASG) is expected to reach an average price of $ in , with a high prediction of $ and a low estimate of $
As on 27th Aug PASG STOCK Price closed @ and we RECOMMEND N/A for LONG-TERM with Stoploss of & N/A for SHORT-TERM with Stoploss of we also. Trade Passage Bio, Inc. - PASG CFD ; Overnight fee time, (UTC) ; Min traded quantity, 1 ; Currency, USD ; Margin, % ; Stock exchange, United States of. Passage Bio, Inc. (US:PASG) has 63 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These. Passage Bio is at this time projected to have valuation of ( M) with market capitalization of M, debt of M, and cash on hands of M. Discover all the factors affecting Passage Bio's share price. PASG is currently rated as a Neutral | Stockopedia.
PPI PRE-RATE CUT - Stock Market LIVE, Live Trading, Stocks To Buy NOW
Sorare Fantasy Football | How To Get Live Pictures On Google Earth